Parkinsonism and psychopathology severity in real-world outpatients with schizophrenia: A cross-sectional PRISM study.
Parkinsonism and psychopathology severity in real-world outpatients with schizophrenia: A cross-sectional PRISM study.
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
Universidad, ES · Author affiliation
Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, ISCIII, School of Medicine, Universidad Complutense, Madrid, Spain; Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK. Electronic address: jgalva01@ucm.es.Location evidence
Madrid, ES · Author affiliation
Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, ISCIII, School of Medicine, Universidad Complutense, Madrid, Spain; Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK. Electronic address: jgalva01@ucm.es.Location evidence
London, GB · Author affiliation
Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, ISCIII, School of Medicine, Universidad Complutense, Madrid, Spain; Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK. Electronic address: jgalva01@ucm.es.Location evidence
Leiden, NL · Author affiliation
Department of Psychiatry, Leiden University Medical Center (LUMC), Leiden, the Netherlands.Location evidence
Amsterdam, NL · Author affiliation
Department of Psychiatry, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.Location evidence
Groningen, NL · Author affiliation
Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, the Netherlands.Location evidence
La Paz, ES · Author affiliation
Department of Psychiatry, Clinical Psychology and Mental Health, Hospital Universitario La Paz, IdiPAZ, CIBERSAM, ISCIII, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.Location evidence
A plain-language reading has not been prepared for this paper yet.
Original abstract
Extrapyramidal symptoms (EPS) have been described as intrinsic to schizophrenia spectrum disorders (SSD), beyond medication-induced effects. Among EPS, parkinsonism is the most prevalent subtype and has been linked to poorer clinical and functional outcomes. We aimed to examine the relationships between parkinsonism and psychopathology and social functioning, as well as its demographic and pharmacological correlates, in a real-world sample of outpatients with schizophrenia receiving stable antipsychotic medication. Data were drawn from the PRISM project, an EU-funded, multicentre, cross-sectional, naturalistic study. Parkinsonism was assessed with the Extrapyramidal Symptoms Rating Scale (ESRS). Patients aged 18-45 years with a confirmed DSM-IV diagnosis of schizophrenia were included if clinically stable on unchanged antipsychotic dosage for ≥ 8 weeks and excluded if scoring > 22 on the PANSS-Positive subscale or ≥ 4 on the ESRS. Associations were analysed using correlation and regression models adjusted for relevant covariates, including antipsychotic exposure. Ninety patients were included (mean age 31.53 ± 6.64 years; 36.7% female; 27.8% "other than White"). Parkinsonism prevalence was 51% (ESRS≥1), higher among "other than White" participants (80% vs. 40%, χ2p < 0.001). Parkinsonism was not significantly associated with antipsychotic dose, route, or generation, nor with concomitant psychotropic use (all p > 0.05). Parkinsonism severity correlated with PANSS-Positive (rₛ = 0.228, p = 0.031), PANSS-Negative (rₛ = 0.278, p = 0.008), PANSS-General (rₛ = 0.210, p = 0.047), and PANSS-Total (rₛ = 0.283, p = 0.007). In adjusted regression models, associations remained significant for PANSS-Negative (β = 0.276, p = 0.019) and PANSS-Total (β = 0.234, p = 0.043). No significant associations were observed with social functioning. These findings suggest that parkinsonism is closely associated with clinical symptom severity and may reflect core illness-related features of schizophrenia.